Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.

Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.

Item
http://www.wikidata.org/entity/Q34058557
Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsQuantifying progression and regression of thrombotic risk in experimental atherosclerosisPerfluorocarbon nanoparticles for physiological and molecular imaging and therapyRapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac functionInhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental AtherosclerosisIntravascular photoacoustic imaging of exogenously labeled atherosclerotic plaque through luminal blood.Melittin derived peptides for nanoparticle based siRNA transfection.Nanomedicines for Endothelial Disorders.Mesoporous Silica Nanoparticles with Co-Condensed Gadolinium Chelates for Multimodal Imaging.Molecular MRI of the Cardiovascular System in the Post-NSF EraVisualizing the atherosclerotic plaque: a chemical perspective.Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice
P2860

Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.

Item
http://www.wikidata.org/entity/Q34058557
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Quantifying the evolution of v ...... nanoparticle contrast agents.
@ast
Quantifying the evolution of v ...... nanoparticle contrast agents.
@en
Quantifying the evolution of v ...... nanoparticle contrast agents.
@nl
type
label
Quantifying the evolution of v ...... nanoparticle contrast agents.
@ast
Quantifying the evolution of v ...... nanoparticle contrast agents.
@en
Quantifying the evolution of v ...... nanoparticle contrast agents.
@nl
prefLabel
Quantifying the evolution of v ...... nanoparticle contrast agents.
@ast
Quantifying the evolution of v ...... nanoparticle contrast agents.
@en
Quantifying the evolution of v ...... nanoparticle contrast agents.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Quantifying the evolution of v ...... nanoparticle contrast agents.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0026385
P407
P433
P478
P577
P5875
P698
P921
P932